The stock of Roivant Sciences Ltd (NASDAQ:ROIV) last traded at $11.80, up 1.55% from the previous session.
ROIV stock price is now 0.16% away from the 50-day moving average and 6.35% away from the 200-day moving average. The market capitalization of the company currently stands at $8.73B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $17, Wolfe Research recently initiated with Outperform rating for Roivant Sciences Ltd (NASDAQ: ROIV). On January 05, 2024, Piper Sandler recently initiated its ‘Overweight’ rating on the stock quoting a target price of $20, while ‘Deutsche Bank’ rates the stock as ‘Buy’
In other news, Venker Eric, President & COO sold 100,000 shares of the company’s stock on Oct 21 ’24. The stock was sold for $1,165,000 at an average price of $11.65. Upon completion of the transaction, the President & COO now directly owns 617,470 shares in the company, valued at $7.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 21 ’24, Officer Venker Eric bought 100,000 shares of the business’s stock. A total of $1,165,393 was incurred on buying the stock at an average price of $11.65. A total of 49.13% of the company’s stock is owned by insiders.
During the past 12 months, Roivant Sciences Ltd has had a low of $8.24 and a high of $13.06. As of last week, the company has a debt-to-equity ratio of 0.07, a current ratio of 27.91, and a quick ratio of 27.75. The fifty day moving average price for ROIV is $11.7814 and a two-hundred day moving average price translates $11.095 for the stock.
The latest earnings results from Roivant Sciences Ltd (NASDAQ: ROIV) was released for 2024-06-30. The net profit margin was 2991.76% and return on equity was 149.26% for ROIV. The company reported revenue of $55.13 million for the quarter, compared to $21.62 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 154.96 percent.
